Magnesium Supplementation Dosing for Pediatric Patients
For routine oral magnesium supplementation in children, use 0.5 mmol/kg/day (approximately 12 mg elemental magnesium per kg per day) of magnesium chloride or magnesium gluconate solution, with a maximum dose not exceeding 200 mg elemental magnesium daily for most children. 1, 2
Age-Specific Parenteral Dosing Guidelines
For children requiring intravenous magnesium supplementation (such as in parenteral nutrition):
- Toddlers and young children: 0.1 mmol/kg/day (2.4 mg/kg/day) 1
- General pediatric range: 0.1-0.3 mmol/kg/day depending on age and clinical situation 3, 1
This translates to approximately 24-36 mg of elemental magnesium daily from all sources combined for a typical 12-15 kg toddler. 1
Critical Safety Considerations
Commercial magnesium products marketed for children often contain dangerously excessive doses. Many magnesium gummies contain 50-200 mg of elemental magnesium per serving, representing 2-8 times the physiologic requirement for a toddler, and can cause muscle weakness, respiratory depression, cardiac dysfunction, and death. 1, 4
Key Safety Points:
- Young children have higher body-surface-to-mass ratios, increasing vulnerability to systemic toxicity 1
- Renal excretion capacity is limited in young children, particularly if kidney function is compromised 1
- The FDA recommends that children under 6 years should only use magnesium products under medical supervision 1
- Fatal hypermagnesemia has been documented in children receiving unsupervised high-dose magnesium supplementation 4
Oral Formulation Selection
For oral supplementation, magnesium chloride 10% solution is preferred, given at 1.0 mL/kg/day (providing 0.5 mmol/kg/day magnesium). 2
Alternative acceptable formulations include:
- Magnesium gluconate (Magonate) 1.0 mL/kg/day (0.45 mmol/kg/day) 2
- Organic magnesium salts (aspartate, citrate, lactate) have higher bioavailability than magnesium oxide 5
Avoid magnesium oxide as first-line therapy in children despite its higher elemental magnesium content, as it has lower bioavailability compared to organic salts. 5
Monitoring Requirements
Regular monitoring of serum magnesium, calcium, and potassium levels is essential if magnesium supplementation is prescribed. 1
- Normal serum magnesium levels: 0.7-1.5 mmol/L in young children 1
- Check levels at baseline and periodically during treatment 1
- Ensure adequate renal function before and during treatment 1
Special Clinical Populations
Children with CKD or Post-Transplant
In children with chronic kidney disease or post-transplant status, hypomagnesemia commonly occurs as a side effect of calcineurin inhibitors. 3 Increased dietary magnesium intake may be attempted initially; however, the amount required to correct serum levels typically necessitates a magnesium supplement. 3
Neonates with Maternal Magnesium Exposure
For neonates exposed to maternal magnesium therapy, limit magnesium intake and adjust based on postnatal serum concentrations. 6 Hypermagnesemia in neonates born to magnesium-treated eclamptic mothers usually improves after 36 hours of conservative management including calcium salts and IV glucose/saline infusions. 2
Acute Care Settings
For acute severe conditions (asthma, torsades de pointes), use 25-50 mg/kg IV/IO (maximum 2 g) over 10-30 minutes as recommended by the American Academy of Pediatrics and American Heart Association. 6 This is distinct from routine supplementation dosing.
Common Pitfalls to Avoid
- Never assume over-the-counter availability equals safety in pediatric populations 1
- Do not use magnesium citrate as a phosphate binder in children with CKD (it increases aluminum absorption) 3
- Avoid magnesium chloride in patients with metabolic acidosis risk 3
- Have calcium chloride immediately available (20 mg/kg or 0.2 mL/kg of 10% solution IV) to reverse magnesium toxicity 6
Maintenance Fluid Therapy Context
In acutely and critically ill children receiving IV maintenance fluid therapy, there is insufficient evidence to recommend routine supplementation of magnesium in the absence of documented deficiency or specific clinical indications. 3 Supplementation should be guided by serum levels and clinical status rather than routine prophylaxis.